Protein palmitoylation and depalmitoylation alter protein function. This post-translational modification is critical 17 for synaptic transmission and plasticity. Mutation of the depalmitoylating enzyme palmitoyl-protein thioesterase 18
Introduction 29
The neuronal ceroid lipofuscinoses (NCLs) are a class of individually rare, primarily autosomal recessive, 30 neurodegenerative diseases occurring in an estimated 2 to 4 of 100,000 live births (Nita et al., 2016) . Collectively, 31
NCLs represent the most prevalent class of hereditary pediatric neurodegenerative disease (Haltia, 2006 Protein palmitoylation, the addition of a 16-carbon fatty acid (palmitic acid) to cysteine residues, is a crucial how depalmitoylation regulates the turnover of these proteins, let alone during the GluN2B to GluN2A subunit 81 switch, is unclear. 82
In the current study, we investigated the cellular and synaptic effects of PPT1-deficiency using the Ppt1 -/-83 mouse model of CLN1 disease. We focused on the visual system in Ppt1 -/-animals for two reasons. First, cortical 84 blindness is a characteristic feature of CLN1 disease. Second, the rodent visual system is a well-studied model of 85 cortical development and synaptic plasticity/maturation and it therefore serves as an optimal experimental model 86 to examine the role of PPT1-mediated depalmitoylation during development. We found that lipofuscin 87 accumulated very early in the Ppt1 -/-visual cortex, shortly after eye-opening at postnatal day (P) 14, a timing 88 earlier than previously documented (Gupta et al., 2001 to GluN2A subunit switch and synaptic maturation. Further, our results indicate that these dysregulated 99 mechanisms contribute to CLN1 pathophysiology and may be shared features of common adult-onset 100 neurodegenerative diseases. 101 6 P11 to P60, and measured levels of GluN2B and GluN2A subunits in whole lysates and synaptosomes of WT and 142 Ppt1 -/-visual cortices. Whereas GluN2B levels were comparable between WT and Ppt1 -/-at all ages, GluN2A 143 levels in synaptosomes were significantly lower in Ppt1 -/-than WT (Figure 2A ). This decrease was present at 144 time points during, and just following, the critical period in visual cortical development (P33, P42, and P60). 145
When analyzed as a ratio of GluN2A/GluN2B, a robust and persistent decrease is observed in Ppt1 -/-visual cortex 146 ( Figure 2B ). GluN1 levels were unchanged between WT and Ppt1 -/-in synaptosomes ( Figure 2C GluN2B and GluN2A, while SAP102 levels remained unchanged, we observed a decrease in PSD-95 levels at 156 P33-P60, the same developmental time points where GluN2A expression was reduced ( Figure 2D ). Together, 157 these results suggest reduced incorporation and scaffolding of GluN2A-containing NMDARs in Ppt1 -/-synapses, 158
indicating immature or dysfunctional synaptic composition. 159
To examine whether the reduction in GluN2A is due to selective exclusion from the postsynaptic site or 160 alterations in the total protein amount, we also measured NMDAR subunit levels in whole lysates. These findings 161 closely match our findings in synaptosomes. Namely, GluN2A levels showed reductions in Ppt1 -/-lysates 162 beginning at the same time point (P33), while GluN2B levels were stable (Supplementary Figure 1A) . The 163
GluN2A/2B ratios in Ppt1 -/-whole lysates were also lower than those in WT lysates and the reduction was 164 comparable to that observed in synaptosomes. (Supplementary Figure 1B) . GluN1 levels, however, were 165 unaltered between genotypes (Supplementary Figure 1C) NMDA-EPSCs were pharmacologically isolated (see Methods section) and were recorded in whole cell patch 176 mode clamped at +50mV ( Figure 3A) . As GluN2A-and GluN2B-containing NMDARs exhibit differential 177 receptor kinetics, with GluN2A displaying fast (~50ms) and GluN2B displaying slow decay kinetics (~300ms), 178 their relative contribution is reliably interpolated by fitting the EPSC decay phase with a double exponential 179 function (Stocca and Vicini, 1998; Vicini et al., 1998) . From the fitting, we measured the following parameters: 180 the amplitude (A) of the fast (Af) and slow (As) components; the ratio Af/ Af+As; the decay time constants ( ) of 181 the fast ( f) and the slow components ( s), and the weighted decay ( w). Ppt1 -/-mice showed significant decreases 182 in the Af and ratio of Af/Af+As as compared to WT, while As showed no significant change ( Figure 3B) . Further, 183 7 the f significantly decreased in Ppt1 -/-mice vs. WT, while w and s were comparable ( Figure 3C ). 
225
/-neurons at DIV10 and decreasing thereafter ( Figure 5A ). In contrast, levels of both GluN2A and PSD-95 226 remained low until DIV18, at which point expression was robust ( Figure 5B, C) . Importantly, GluN2A, PSD-95, 227
and GluN2A/GluN2B ratio levels were reduced in Ppt1 -/-neurons compared to WT at DIV18, indicating that the 228 biochemical phenotype is recapitulated to an extent in vitro (Figure 5B-D Figure 6A ). We measured dendritic spine length and volume in transfected cells using 232 the Imaris software (Bitplane). At both DIV 15 and 20, we observed a significant shift in the dendritic spine length 233 and volume (Figure 6B and C) . Ppt1 -/-neurons demonstrated a significantly higher percentage of long, thin 234 protrusions (filipodia-type; Figure 6B) , and a significant reduction in the percentage of mature, mushroom-type 235 dendritic spines with volumes greater than 0.2 m 3 ( Figure 6C ). When averaged, the data demonstrate a robust 236 increase in mean spine length and a decrease in spine volume in Ppt1 -/-neurons compared to WT controls at both 237 time points (Figure 6B and C, To quantitatively compare these properties, we performed 260 measurements of area under the curve (AUC) and calcium diffusion distance (see shaded region in Figure 7C ) 261 for each synaptic site from WT and Ppt1 -/-neurons. These analyses revealed a robust increase in both the AUC 262 ( Figure 7D ) and the calcium diffusion distance ( Figure 7E) Figure 9A and B) . Immunostaining for a marker of lysosomal compartments, 300 lysosomal-associated membrane protein-2 (LAMP-2), corroborated these findings, revealing that the observed 301 AL accumulates within lysosomes of Ppt1 -/-but not WT neurons (vehicle treatment in Figure 9B ). Further, 302 lysosomes appeared swollen in vehicle-treated Ppt1 -/-neurons (see arrows in Figure 9B ). Treatment with the 303 palmitoylation inhibitors, 2-bromopalmitate (2-BP, 1 M, 7-day treatment) and cerulenin (1 M, 7-day treatment) 304 reduced the percentage of AL-positive neurons ( Figure 9C ) and the area occupied with ALs per neuron ( Figure  305 9D). Further, the mean lysosomal size also normalized in Ppt1 -/-neurons when these cells were treated with 2-BP 306 or cerulenin ( Figure 9E) . 307
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To examine the efficacy of these compounds in preventing NMDA-mediated toxicity, we pretreated a 308 subset of neurons with the same palmitoylation inhibitors, 2-BP (1 M, DIV12-18) and cerulenin (1 M, DIV12-309 18) prior to treatment with NMDA and glycine. Notably, pretreatment with both 2-BP and cerulenin improved 310 cell viability of Ppt1 -/-neurons to that of WT following excitotoxicity induction ( Figure 8F ). These results 311
indicate Ppt1 -/-neurons are more vulnerable to excitotoxicity and are consistent with our calcium imaging data 312 that demonstrated the predominance of extrasynaptic, GluN2B-mediated NMDAR activity. 313
Palmitoylation inhibitors rescue GluN2B and Fyn kinase hyperpalmitoylation in Ppt1 -/-neurons 314
Finally, we directly examined the palmitoylation state of neuronal proteins to determine the mechanisms by 315 which hyperpalmitoylation of neuronal substrates may lead to NMDA-mediated excitotoxicity and asked whether 316 palmitoylation inhibitors correct these abnormalities. In particular, we focused on GluN2B palmitoylation, given 317 our evidence implicating GluN2B in the synaptic dysfunction present in Ppt1 -/-neurons. We employed a modified 318 acyl-biotin exchange procedure (Drisdel and Green, 2004), termed the APEGS assay (acyl-PEGyl exchange gel-319 shift) (Yokoi et al., 2016) . The APEGS assay effectively tags the palmitoylation sites of neuronal substrates with 320 a 5kDa polyethylene glycol (PEG) polymer, causing a molecular weight-dependent gel shift in immunoblot 321
analyses. Thus, we quantitatively analyzed the palmitoylated fraction of synaptic proteins and palmitoylated 322 signaling molecules that may influence NMDAR function. 323
We subjected DIV18 WT and Ppt1 -/-primary cortical neuron lysates to the APEGS assay to determine the 324 palmitoylation state of GluN2B. Indeed, GluN2B palmitoylation was increased in Ppt1 -/-neurons compared to 325
WT at DIV18 ( Figure 10A ). This suggests enhanced surface retention of GluN2B-containing NMDARs in Ppt1 Here, we have identified the novel mechanism whereby impaired GluN2B to GluN2A subunit switch contributes 377 to the core pathophysiology of a pediatric neurodegenerative disease. 378
We have demonstrated a novel role for PPT1 in the regulation of palmitoylated postsynaptic proteins. In 379 particular, lack of PPT1 disrupts the NMDA receptor GluN2B to GluN2A subunit switch characteristic of 380 excitatory synaptic maturation. Initially, we predicted synaptic markers, particularly PSD-95, would be 381 (Figure 7 and Video 2) and that they are more susceptible to excitotoxicity (Figure 8) . 437 Furthermore, the most significant outcome of this study is that palmitoylation inhibitors mitigated the pro-438 apoptotic predisposition of Ppt1 -/-neurons in vitro (Figure 9 ). HEPES, pH7.4 containing 1x protease inhibitor cocktail (Roche), 1x phosphatase inhibitor cocktail (Roche) and 504 1mM PMSF) using 30 strokes in a Dounce homogenizer. Aliquots for whole lysate (WL) were stored and the 505 remaining sample was used for synaptosome preparation, performed as previously with slight modification. In 506 brief, WLs were centrifuged at 1,000 x g to remove cellular debris, supernatant was then centrifuged at 12,000 x 507 g for 15min to generate pellet P2. P2 was resuspended in synaptosome buffer and spun at 18,000 x g for 15min 508
to produce synaptosomal membrane fraction, LP1, which was used for downstream biochemical analyses 509 (synaptosomes). For immunoblot, protein concentration of each sample was determined using BCA protein assay 510 (Pierce). Samples were then measured to 20 g total protein in 2x Laemmli buffer containing 10% -511 mercaptoethanol (Bio-rad), boiled at 70°C for 10min and loaded into 10% tris-glycine hand cast gels (Bio-rad), 512 or 4-20% precast gels (Bio-rad) for electrophoresis (110V, 1.5-2h). Proteins were wet-transferred to PVDF 513 membranes (Immobilon-P, Millipore), blocked in TBS, pH7.4 containing 5% non-fat milk and 0.1% Tween-20 514 (TBS-T+5% milk). Membranes were incubated in primary antibody solutions containing 2% BSA in TBS-T for 515 2h at RT or overnight at 4°C. Primary antibodies were used as follows: GluN2A (Cat: NB300-105 
containing DAPI (Vector Laboratories, cat: H-5000). Interlaced/overlapping images of visual cortex area V1 from 533 the cortical surface to subcortical white matter (or subiculum), which was localized using Paxino's mouse atlas 534 (sagittal), were collected for 2-4 sections from each animal using a Zeiss LSM710 confocal laser scanning 535 microscope at 40x magnification (excitation at 405nm to visualize DAPI and 561nm to visualize AL). All sections 536
were imaged using identical capture conditions. Quantification of AL was performed by thresholding images in 537 FIJI (NIH), generating a binary mask of AL-positive pixels (satisfied threshold) vs. background. The identical 538 threshold was applied to each image (from cortical surface to subcortical white matter and across animals). 539
Percent area occupied by AL puncta that satisfied the threshold was then calculated using the "analyze particles" 540 tool in FIJI. This analysis was performed for 2-4 sections (total of ~10-20 images, as imaging an entire cortical 541 column is typically 5 interlaced images) from each animal and averaged together to give a single value, 542
representative of the total area occupied by AL in the cortical column imaged. Three to six animals per group 543 were analyzed this way and averaged to give the mean area occupied by AL at each time point, for both genotypes 544 (n=4-6 animals/group). 545 Electrophysiology 546
WT and Ppt1 -/-animals at P42 were deeply anesthetized using isoflurane drop method and decapitated. 547
Brains were resected in semi-frozen oxygenated (95% O2 and 5% CO2) artificial cerebrospinal fluid (aCSF, in 548 mM: NaCl 85, sucrose 75, KCl 2.5, CaCl2 0.5, MgCl2 4, NaHCO3 24, NaH2PO4 1.25, D-glucose 25, pH 7.3), and 549 350µm sections containing visual cortex area V1 were sectioned using a Leica VT1200 S vibratome in semi-550 frozen aCSF. After recovery (1h) in aCSF at 30°C, sections were transferred to the recording chamber, perfused 551 at 2ml/min with aCSF at 30°C. Following localization of visual cortex area V1 using Paxinos mouse brain atlas, 552 a stimulating electrode was placed in layer IV, and pyramidal neurons from layer II/III were blindly patched 553 (patch solution in mM: CsOH monohydrate 130, D-Gluconic acid 130, EGTA 0.2, MgCl2 1, CsCl 6, Hepes 10, 554 Na2-ATP 2.5, Na-GTP 0.5, Phoshocreatine 5, QX-314 3; pH 7.3, osmolarity 305 mOsm) and recorded in voltage 555 clamp mode at +50mV (VH) to remove Mg 2+ block from NMDARs. NMDA-EPSCs were pharmacologically 556 isolated via addition of CNQX (10μM), (+)-Bicuculline (60 μM) and SCH 50911 to block AMPA, GABAA and 557 GABAB receptors, respectively. Stimulation intensity was titrated to give a saturating postsynaptic response, and 558
EPSCs were then recorded, averaging 5-10 sweeps. The decay phase of the averaged NMDAR-EPSCs were then 559 fitted to a double exponential (Carmignoto and Vicini, 1992) . We calculated for each cell: the amplitude of the 560 fast (Af) component (GluN2A-mediated), the amplitude of the slow (As) component (GluN2B-mediated), the 561 contribution of the fast component Af/ Af+As to the overall decay phase, the fast ( f), the slow ( s) and the 562 weighted ( w) in WT and Ppt1 -/-mice following this formula: w= fx(Af/Af+As) + sx(As/Af+As) (n=10/4 563 (cells/animals), WT; n=12/5 PPT-KO). 564
In utero electroporation 565
In utero electroporation was performed as previous (Yoshii et al., 2011 (Yoshii et al., , 2013 . Timed-pregnant dams at E16.5 566 were deeply anesthetized via isoflurane (3% induction, 1-1.5% for maintenance of anesthesia during surgery) and 567 laparotomized. The uterus was then externalized and up to ~1μl of solution containing GFP construct (2μg/μl) 568 and fast green dye was delivered into the left lateral ventricle through the uterine wall using a micropipette. Using 569 an ECM 830 Square Wave electroporator (Harvard Apparatus, Holliston MA), brains were electroporated with 5 570 pulses of 28V for 50msec at intervals of 950msec at such an angle to transfect neurons in visual cortex. After 571 recovery, pregnancies were monitored and pups were delivered and nursed normally. Electroporated pups were 572 genotyped, raised to P33, and sacrificed via transcardial perfusion as described above. Electroporated brains from 573 WT and Ppt1 -/-mice (procedure schematized in Figure 4A ) were sectioned and sequentially mounted. Transfected 574 neurons in visual cortex ( Figure 4B ) were imaged to capture all apical neurites and 3D reconstructed images were 575 analyzed in Imaris (Bitplane) for dendritic spine characteristics known to be associated with synaptic maturity 576 (spine length, spine volume, and spine head volume). At least two z-stack images (typically >100 z-planes/image) 577
were stitched together to capture the prominent apical neurites and extensions into the cortical surface for each 578 cell. Each stitched image, equivalent to one cell, was considered one n. were plated on poly-D-lysine/laminin-coated 6-well plates at 1,000,000 cells/well. Cells were plated and stored 588 in plating medium (Neurobasal medium containing B27 supplement, L-glutamine and glutamate) for 3-5 DIV, 589 before replacing half medium every 3 days with feeding medium (plating medium without glutamate). Cultures 590 used in chronic palmitoylation inhibitor treatment were exposed to either DMSO (vehicle), 2-BP (1 m, Sigma, 591 cat: 238422) or cerulenin (1 m, Cayman Chemicals, cat: 10005647) every 48 hours between DIV 11 and 18. 592
Primary cortical neuron harvest and immunoblotting 593 Primary cortical neurons from E15.5 WT and Ppt1-/-embryos were cultured for 7, 10, or 18 DIV prior to harvest 594 for immunoblot or APEGS assay (only DIV18 used for APEGS). To harvest protein extracts, cells were washed 595 2x with ice-cold PBS before addition of lysis buffer containing 1% SDS and protease inhibitor cocktail, 596 500 l/well. Cells were incubated and swirled with lysis buffer for 5 minutes, scraped from the plate, triturated 597 briefly, and collected in 1.5ml tubes. Lysates were centrifuged at 20,000g for 15min to remove debris, and the 598 supernatant was collected for biochemical analysis. Immunoblotting analyses were performed as in section 2.2. 599 APEGS assay was carried out as described in section 2.7. 600 APEGS assay on primary cortical neuron lysates 601
The APEGS assay was performed as utilized in Yokoi, 2016 and recommended by Dr. M. Fukata (personal 602 communication, 06/2018). Briefly, cortical neuron lysates were brought to 150 g total protein in a final volume 603 of 0.5ml buffer A (PBS containing 4% SDS, 5mM EDTA, protease inhibitors, remaining sample used in aliquots 604
for "input"). Proteins were reduced by addition of 25mM Bond-Breaker™ TCEP (0.5M stock solution, 605 ThermoFisher) and incubation at 55°C for 1h. Next, to block free thiols, freshly prepared N-ethylmaleimide 606 (NEM) was added to lysates (to 50mM) and the mixture was rotated end-over-end for 3h at RT. Following 2x 607 chloroform-methanol precipitation (at which point, protein precipitates were often stored overnight at -20°C), 608 lysates were divided into +hydroxylamine (HA) and -HA groups for each sample, which were exposed to 3 609 volumes of HA-containing buffer (1M HA, to expose palmitolylated cysteine residues) or Tris-buffer control (-610 HA, see Figure 10 ), respectively, for 1h at 37°C. Following chloroform-methanol precipitation, lysates were 611 solubilized and exposed to 10mM TCEP and 20mM mPEG-5k (Laysan Bio Inc., cat# MPEG-MAL-5000-1g) for 612 1h at RT with shaking (thereby replacing palmitic acid with mPEG-5K on exposed cysteine residues). Following 613 18 the final chloroform-methanol precipitation, samples were solubilized in a small volume (60 l) of PBS containing 614 1% SDS and protein concentration was measured by BCA assay (Pierce). Samples were then brought to 10 g 615 protein in laemmli buffer with 2% -mercaptoethanol for immunoblot analyses as in section 2.2. Quantification 616 of palmitoylated vs. non-palmitoylated protein was carried out as in section 2.2, with the added consideration that 617 palmitoylated protein was taken as the sum of all (typically two-three distinct bands, see Figure 9 ) bands 618 demonstrating the APEGS-dependent molecular weight shift compared to the -HA control lane. To directly image calcium signals in WT and Ppt1 -/-neurons, cells were transfected as above using the 636 construct encoding GCaMP3 (see Acknowledgments) at DIV6-8. Cells were grown to DIV18 then imaged at 637 room temperature in Tyrode's solution (imaging medium, 139mM NaCl, 3mM KCl, 17mM NaHCO3, 12mM 638 glucose, and 3mM CaCl2) for a maximum of 15min using a Mako G-507B camera mounted onto a Leica inverted 639 microscope. Videos were acquired at ~7 frames per second using StreamPix software (NorPix). A maximum of 640 5min per neuron was recorded (thus, minimum 3 neurons per coverslip were acquired). N=3-6 neurons/group, 641 three independent experiments. For treatment with Ro 25-6981, neurons were imaged at baseline for 2-2.5min 642 before adding Ro 25-6981 (1 M) directly to the imaging medium. Neurons were then imaged for an additional 643 2.5min. 644
To analyze the area under the curve (AUC) and width (diffusion distance) of calcium transients, 500-600 645 frames from the middle of each video (average frame count for whole videos= ~2000 frames) for WT and Ppt1 -/-646 neurons were analyzed using FIJI (NIH). Dendritic segments, excluding primary dendrites, were traced using a 647 segmented line ROI with pixel width of 50, which reliably encompassed the dendritic segment and accompanying 648 dendritic spines. Next, the following macro derived from the ImageJ forum (http://forum.imagej.net/t/how-to-649 obtain-xy-values-from-repeated-profile-plot/1398) was run on each individual ROI: 650 macro "Stack profile Plot" { treated neurons, the same protocol was followed with the exception that calcium transients at an individual 703 synaptic site were split into "before application" and "after application" groups.
704
To analyze synaptic synchrony, F/F0 measurements for 20 randomly-chosen sites of synaptic activity 705 per neuron were correlated across the time dimension (500 frames of each video). A correlation matrix was 706 20 generated to determine the average correlation of each synaptic site with all other chosen sites. The average values 707 for each synaptic site, for 5 neurons/group are plotted in Figure 7 . 708 NMDA toxicity assays 709
To measure cell viability following exposure of WT and Ppt1 -/-neurons to NMDA and glycine, neurons 710 were plated as above and grown to DIV18. For experiments presented in Figure 6 , feeding medium was removed 711 from neurons, stored at 37°C, and replaced with B27-free Neurobasal medium with or without NMDA/glycine at 712 the following concentrations: 10/1 M, 100/10 M, or 300/30 M (ratio maintained at 10:1). Cells were incubated 713 for 2h at 37°C in treatment medium. Following incubation, treatment medium was removed and replaced with 714 the original feeding medium. Cells were then incubated an additional 22h before addition of PrestoBlue® cell 715 viability reagent (ThermoFisher). At 24h, fluorescence intensity of each well was measured using a Beckman 716
Coulter DTX 800 Multimode Detector. Cell viability for each treatment condition was calculated and expressed 717 as percentage of vehicle-treated control wells (no pretreatment, no NMDA application). Experiments in Figure 7  718 were performed similarly except that cultures were pretreated with either DMSO (vehicle), imaged at random using a Zeiss LSM 710 confocal microscope at 63x magnification. Z-stacks (0.4 m Z-plane 727 interval, 12-22 Z-planes/image) were taken at 512 x 512 pixel density. 7-10 neurons/group for three independent 728 experiments.
729
To semi-automatically analyze the percentage of AL-containing cells, the cytosolic area covered by AL 730 deposits, and the cytosolic area covered by lysosomes, images immunostained for MAP2 and LAMP-2 were 731 processed in FIJI. Each channel of the image: LAMP-2 (488nm), MAP2 (633nm), DAPI (405nm), AL (561nm) 732 was thresholded separately as to display only the lysosomes, cell soma, the nucleus, and AL deposits, respectively. 733
Thresholds were kept identical between images. Next, the areas of these compartments/deposits were measured 734 using the "analyze particles" tool restricted to an ROI tracing the cell soma. Lysosomes needed to have a 735 circularity of >0.5 to avoid counting small clusters of lysosomes as a single unit (Bandyopadhyay et al., 2014; 736 Grossi et al., 2016). To measure AL deposits, the same approach was used with the additional constraint: AL 737 deposits were required to have a circularity >0.4 and comprise more than 8 adjacent pixels. Cytosolic area was 738 calculated by measuring MAP2 signal area and subtracting the area occupied by DAPI stain. 739
Immunocytochemistry 740
Coverslips were stained in runs so that all experimental and control groups were immunostained 741 simultaneously. Coverslips were washed 3x with TBS, permeabilized for 20min at RT with TBS containing 0.5% 742 Triton X-100, and blocked for 1h at RT in TBS containing 0.1% Triton X-100 and 5% BSA. Then, primary 743 antibody (MAP2 or LAMP-2) at 1:400 dilution was added to coverslips in TBS containing 0.1% Triton X-100 744 and 1% BSA and incubated for 2h at RT or overnight at 4 C. Following 4X washes with TBS containing 0.1% 745
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Triton 4 cells/animal, 3 animals/group) using t-test and the significance was indicated as follows: **p<0. Figure 10A , Ppt1 -/-and WT were compared (n=4 independent experiments) by t-386 test and significance was indicated as follows: **p<0.01. For experiments in Figure 10B -C, Ppt1 -/-and WT were 387 compared (n=2-4 independent experiments) at each time point using two-way ANOVA followed by Bonferroni 388 post hoc test and the significance was indicated as follows: *p<0.05, **p<0.01 ***p<0.001. Error bars represent 389
s.e.m. 390
Supplementary Table 1 . Mean values, s.e.m., and n for the bar chart in Figure 1C . 
